InvestorsObserver
×
News Home

Is Beam Therapeutics Inc (BEAM) Stock at the Top of the Biotechnology Industry?

Wednesday, June 22, 2022 01:56 PM | InvestorsObserver Analysts

Mentioned in this article

Is Beam Therapeutics Inc (BEAM) Stock at the Top of the Biotechnology Industry?

The 70 rating InvestorsObserver gives to Beam Therapeutics Inc (BEAM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 88 percent of stocks in the Biotechnology industry, BEAM’s 70 overall rating means the stock scores better than 70 percent of all stocks.

Overall Score - 70
BEAM has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on BEAM!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Beam Therapeutics Inc Stock Today?

Beam Therapeutics Inc (BEAM) stock is trading at $39.28 as of 1:55 PM on Wednesday, Jun 22, a gain of $1.23, or 3.23% from the previous closing price of $38.05. The stock has traded between $34.47 and $39.30 so far today. Volume today is below average. So far 891,943 shares have traded compared to average volume of 1,495,408 shares. Click Here to get the full Stock Report for Beam Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App